… for gastric cancer patients. However, there are currently no biomarkers of acceptable sensitivity
and specificity to detect early stage gastric cancer. … The immunohistochemical analysis of …

… VEGF is highly expressed in most prostate cancers [373, 377… EZH2, Ki-67 and MCM7 are
prognostic markers in … Loss of pRb2/p130 expression is associated with unfavorable clinical …

… study, an immunohistochemical assay was used to detect the expression of EZH2 protein in
endometrial carcinoma … (33), cervical (34), gastric cancer (35) and other malignant tumors, …

… In bladder and gastric cancers, EZH2 was increased at both the mRNA and protein levels in
cancer cell lines and cancer tissue specimens relative to normal controls (Mattioli et al., 2007…

… study, we detected the expression levels of EZH2 in human cervical cancer specimens and
cervical cancer cell … Moreover, we demonstrated the effects of EZH2 down-regulation on cell …

… An immunohistochemistry study for HER2/neu and PDL-1 … , and the tumor protein 53 (TP53)-active
and TP53-inactive types. … The big difference in the expression pattern of PDL-1 can be …

… cancer cell proliferation and survival in gastric cancer and … First, we analysed the expression
pattern of miR-106b in CRC cell … xenograft tumours by immunohistochemistry and found that …

… expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell
carcinoma of … of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. …

… The aim of this study was to evaluate the association of EZH2 genotypes with oral cancer
risk … strong expression of EZH2 in immunohistochemistry, developed oral squamous cell …